nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS1—Alzheimer's disease	0.384	0.636	CbGaD
Mefenamic acid—PTGS2—Alzheimer's disease	0.22	0.364	CbGaD
Mefenamic acid—CYP2C9—Donepezil—Alzheimer's disease	0.0328	1	CbGbCtD
Mefenamic acid—Diclofenac—TTR—Alzheimer's disease	0.00109	0.135	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—TP53—Alzheimer's disease	0.000696	0.086	CrCbGaD
Mefenamic acid—Pneumonia—Donepezil—Alzheimer's disease	0.000682	0.00305	CcSEcCtD
Mefenamic acid—Pancreatitis—Memantine—Alzheimer's disease	0.000677	0.00302	CcSEcCtD
Mefenamic acid—Flatulence—Galantamine—Alzheimer's disease	0.000674	0.00301	CcSEcCtD
Mefenamic acid—Tension—Galantamine—Alzheimer's disease	0.000671	0.003	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000668	0.00299	CcSEcCtD
Mefenamic acid—Renal failure—Donepezil—Alzheimer's disease	0.000666	0.00298	CcSEcCtD
Mefenamic acid—Myocardial infarction—Donepezil—Alzheimer's disease	0.000665	0.00297	CcSEcCtD
Mefenamic acid—Nervousness—Galantamine—Alzheimer's disease	0.000664	0.00297	CcSEcCtD
Mefenamic acid—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000662	0.00296	CcSEcCtD
Mefenamic acid—Jaundice—Donepezil—Alzheimer's disease	0.000661	0.00295	CcSEcCtD
Mefenamic acid—Conjunctivitis—Donepezil—Alzheimer's disease	0.000659	0.00294	CcSEcCtD
Mefenamic acid—Pancytopenia—Memantine—Alzheimer's disease	0.000656	0.00293	CcSEcCtD
Mefenamic acid—Haematuria—Donepezil—Alzheimer's disease	0.000646	0.00289	CcSEcCtD
Mefenamic acid—Dysuria—Memantine—Alzheimer's disease	0.000646	0.00288	CcSEcCtD
Mefenamic acid—Vision blurred—Galantamine—Alzheimer's disease	0.000644	0.00288	CcSEcCtD
Mefenamic acid—Tremor—Galantamine—Alzheimer's disease	0.000641	0.00286	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000634	0.00283	CcSEcCtD
Mefenamic acid—Anaemia—Galantamine—Alzheimer's disease	0.000632	0.00282	CcSEcCtD
Mefenamic acid—Dysuria—Rivastigmine—Alzheimer's disease	0.000632	0.00282	CcSEcCtD
Mefenamic acid—Floctafenine—PTGS1—Alzheimer's disease	0.000626	0.0774	CrCbGaD
Mefenamic acid—Hyperglycaemia—Memantine—Alzheimer's disease	0.000623	0.00278	CcSEcCtD
Mefenamic acid—Pneumonia—Memantine—Alzheimer's disease	0.000619	0.00277	CcSEcCtD
Mefenamic acid—Malaise—Galantamine—Alzheimer's disease	0.000617	0.00275	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000617	0.00275	CcSEcCtD
Mefenamic acid—Vertigo—Galantamine—Alzheimer's disease	0.000614	0.00274	CcSEcCtD
Mefenamic acid—Syncope—Galantamine—Alzheimer's disease	0.000613	0.00274	CcSEcCtD
Mefenamic acid—Haemoglobin—Donepezil—Alzheimer's disease	0.000612	0.00273	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00061	0.00273	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000609	0.00272	CcSEcCtD
Mefenamic acid—Haemorrhage—Donepezil—Alzheimer's disease	0.000609	0.00272	CcSEcCtD
Mefenamic acid—Hepatitis—Donepezil—Alzheimer's disease	0.000609	0.00272	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000607	0.00271	CcSEcCtD
Mefenamic acid—Pneumonia—Rivastigmine—Alzheimer's disease	0.000606	0.00271	CcSEcCtD
Mefenamic acid—Hallucination—Donepezil—Alzheimer's disease	0.000606	0.00271	CcSEcCtD
Mefenamic acid—Renal failure—Memantine—Alzheimer's disease	0.000605	0.0027	CcSEcCtD
Mefenamic acid—Palpitations—Galantamine—Alzheimer's disease	0.000604	0.0027	CcSEcCtD
Mefenamic acid—Myocardial infarction—Memantine—Alzheimer's disease	0.000603	0.0027	CcSEcCtD
Mefenamic acid—Drowsiness—Rivastigmine—Alzheimer's disease	0.000602	0.00269	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000601	0.00268	CcSEcCtD
Mefenamic acid—Loss of consciousness—Galantamine—Alzheimer's disease	0.000601	0.00268	CcSEcCtD
Mefenamic acid—Conjunctivitis—Memantine—Alzheimer's disease	0.000598	0.00267	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000597	0.00267	CcSEcCtD
Mefenamic acid—Urethral disorder—Donepezil—Alzheimer's disease	0.000597	0.00266	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000594	0.00265	CcSEcCtD
Mefenamic acid—Convulsion—Galantamine—Alzheimer's disease	0.000592	0.00265	CcSEcCtD
Mefenamic acid—Renal failure—Rivastigmine—Alzheimer's disease	0.000592	0.00264	CcSEcCtD
Mefenamic acid—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00059	0.00264	CcSEcCtD
Mefenamic acid—Hypertension—Galantamine—Alzheimer's disease	0.00059	0.00264	CcSEcCtD
Mefenamic acid—Haematuria—Memantine—Alzheimer's disease	0.000587	0.00262	CcSEcCtD
Mefenamic acid—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000585	0.00261	CcSEcCtD
Mefenamic acid—Anxiety—Galantamine—Alzheimer's disease	0.00058	0.00259	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000578	0.00258	CcSEcCtD
Mefenamic acid—Discomfort—Galantamine—Alzheimer's disease	0.000575	0.00257	CcSEcCtD
Mefenamic acid—Agranulocytosis—Memantine—Alzheimer's disease	0.000574	0.00257	CcSEcCtD
Mefenamic acid—Haematuria—Rivastigmine—Alzheimer's disease	0.000574	0.00256	CcSEcCtD
Mefenamic acid—Dry mouth—Galantamine—Alzheimer's disease	0.000569	0.00254	CcSEcCtD
Mefenamic acid—Tinnitus—Donepezil—Alzheimer's disease	0.000567	0.00253	CcSEcCtD
Mefenamic acid—Confusional state—Galantamine—Alzheimer's disease	0.000563	0.00251	CcSEcCtD
Mefenamic acid—Haemoglobin—Memantine—Alzheimer's disease	0.000555	0.00248	CcSEcCtD
Mefenamic acid—Haemorrhage—Memantine—Alzheimer's disease	0.000553	0.00247	CcSEcCtD
Mefenamic acid—Hepatitis—Memantine—Alzheimer's disease	0.000553	0.00247	CcSEcCtD
Mefenamic acid—Hallucination—Memantine—Alzheimer's disease	0.00055	0.00246	CcSEcCtD
Mefenamic acid—Shock—Galantamine—Alzheimer's disease	0.000549	0.00245	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000546	0.00244	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Memantine—Alzheimer's disease	0.000546	0.00244	CcSEcCtD
Mefenamic acid—Tachycardia—Galantamine—Alzheimer's disease	0.000545	0.00243	CcSEcCtD
Mefenamic acid—Arrhythmia—Donepezil—Alzheimer's disease	0.000544	0.00243	CcSEcCtD
Mefenamic acid—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000543	0.00243	CcSEcCtD
Mefenamic acid—Skin disorder—Galantamine—Alzheimer's disease	0.000542	0.00242	CcSEcCtD
Mefenamic acid—Urethral disorder—Memantine—Alzheimer's disease	0.000542	0.00242	CcSEcCtD
Mefenamic acid—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000541	0.00241	CcSEcCtD
Mefenamic acid—Hepatitis—Rivastigmine—Alzheimer's disease	0.000541	0.00241	CcSEcCtD
Mefenamic acid—Hallucination—Rivastigmine—Alzheimer's disease	0.000538	0.0024	CcSEcCtD
Mefenamic acid—Alopecia—Donepezil—Alzheimer's disease	0.000538	0.0024	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000534	0.00238	CcSEcCtD
Mefenamic acid—Mental disorder—Donepezil—Alzheimer's disease	0.000533	0.00238	CcSEcCtD
Mefenamic acid—Anorexia—Galantamine—Alzheimer's disease	0.000532	0.00238	CcSEcCtD
Mefenamic acid—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00053	0.00237	CcSEcCtD
Mefenamic acid—Erythema multiforme—Memantine—Alzheimer's disease	0.000523	0.00233	CcSEcCtD
Mefenamic acid—Flatulence—Donepezil—Alzheimer's disease	0.000522	0.00233	CcSEcCtD
Mefenamic acid—Hypotension—Galantamine—Alzheimer's disease	0.000521	0.00233	CcSEcCtD
Mefenamic acid—Tension—Donepezil—Alzheimer's disease	0.00052	0.00232	CcSEcCtD
Mefenamic acid—Tinnitus—Memantine—Alzheimer's disease	0.000515	0.0023	CcSEcCtD
Mefenamic acid—Nervousness—Donepezil—Alzheimer's disease	0.000515	0.0023	CcSEcCtD
Mefenamic acid—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000511	0.00228	CcSEcCtD
Mefenamic acid—Insomnia—Galantamine—Alzheimer's disease	0.000505	0.00225	CcSEcCtD
Mefenamic acid—Tinnitus—Rivastigmine—Alzheimer's disease	0.000504	0.00225	CcSEcCtD
Mefenamic acid—Paraesthesia—Galantamine—Alzheimer's disease	0.000501	0.00224	CcSEcCtD
Mefenamic acid—Vision blurred—Donepezil—Alzheimer's disease	0.000499	0.00223	CcSEcCtD
Mefenamic acid—Tremor—Donepezil—Alzheimer's disease	0.000496	0.00222	CcSEcCtD
Mefenamic acid—Somnolence—Galantamine—Alzheimer's disease	0.000496	0.00222	CcSEcCtD
Mefenamic acid—Arrhythmia—Memantine—Alzheimer's disease	0.000494	0.00221	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000492	0.0022	CcSEcCtD
Mefenamic acid—Dyspepsia—Galantamine—Alzheimer's disease	0.000491	0.00219	CcSEcCtD
Mefenamic acid—Anaemia—Donepezil—Alzheimer's disease	0.00049	0.00219	CcSEcCtD
Mefenamic acid—Alopecia—Memantine—Alzheimer's disease	0.000488	0.00218	CcSEcCtD
Mefenamic acid—Decreased appetite—Galantamine—Alzheimer's disease	0.000485	0.00217	CcSEcCtD
Mefenamic acid—Mental disorder—Memantine—Alzheimer's disease	0.000484	0.00216	CcSEcCtD
Mefenamic acid—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000483	0.00216	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000482	0.00215	CcSEcCtD
Mefenamic acid—Malaise—Donepezil—Alzheimer's disease	0.000478	0.00213	CcSEcCtD
Mefenamic acid—Alopecia—Rivastigmine—Alzheimer's disease	0.000478	0.00213	CcSEcCtD
Mefenamic acid—Constipation—Galantamine—Alzheimer's disease	0.000477	0.00213	CcSEcCtD
Mefenamic acid—Vertigo—Donepezil—Alzheimer's disease	0.000476	0.00213	CcSEcCtD
Mefenamic acid—Syncope—Donepezil—Alzheimer's disease	0.000475	0.00212	CcSEcCtD
Mefenamic acid—Flatulence—Memantine—Alzheimer's disease	0.000474	0.00212	CcSEcCtD
Mefenamic acid—Mental disorder—Rivastigmine—Alzheimer's disease	0.000474	0.00212	CcSEcCtD
Mefenamic acid—Tension—Memantine—Alzheimer's disease	0.000472	0.00211	CcSEcCtD
Mefenamic acid—Nervousness—Memantine—Alzheimer's disease	0.000467	0.00209	CcSEcCtD
Mefenamic acid—Loss of consciousness—Donepezil—Alzheimer's disease	0.000466	0.00208	CcSEcCtD
Mefenamic acid—Flatulence—Rivastigmine—Alzheimer's disease	0.000464	0.00207	CcSEcCtD
Mefenamic acid—Tension—Rivastigmine—Alzheimer's disease	0.000462	0.00206	CcSEcCtD
Mefenamic acid—Feeling abnormal—Galantamine—Alzheimer's disease	0.00046	0.00205	CcSEcCtD
Mefenamic acid—Convulsion—Donepezil—Alzheimer's disease	0.000459	0.00205	CcSEcCtD
Mefenamic acid—Hypertension—Donepezil—Alzheimer's disease	0.000457	0.00204	CcSEcCtD
Mefenamic acid—Nervousness—Rivastigmine—Alzheimer's disease	0.000457	0.00204	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000456	0.00204	CcSEcCtD
Mefenamic acid—Vision blurred—Memantine—Alzheimer's disease	0.000453	0.00203	CcSEcCtD
Mefenamic acid—Tremor—Memantine—Alzheimer's disease	0.000451	0.00201	CcSEcCtD
Mefenamic acid—Anxiety—Donepezil—Alzheimer's disease	0.00045	0.00201	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Memantine—Alzheimer's disease	0.000446	0.00199	CcSEcCtD
Mefenamic acid—Discomfort—Donepezil—Alzheimer's disease	0.000446	0.00199	CcSEcCtD
Mefenamic acid—Anaemia—Memantine—Alzheimer's disease	0.000445	0.00199	CcSEcCtD
Mefenamic acid—Vision blurred—Rivastigmine—Alzheimer's disease	0.000444	0.00198	CcSEcCtD
Mefenamic acid—Dry mouth—Donepezil—Alzheimer's disease	0.000441	0.00197	CcSEcCtD
Mefenamic acid—Abdominal pain—Galantamine—Alzheimer's disease	0.000441	0.00197	CcSEcCtD
Mefenamic acid—Body temperature increased—Galantamine—Alzheimer's disease	0.000441	0.00197	CcSEcCtD
Mefenamic acid—Tremor—Rivastigmine—Alzheimer's disease	0.000441	0.00197	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000437	0.00195	CcSEcCtD
Mefenamic acid—Confusional state—Donepezil—Alzheimer's disease	0.000436	0.00195	CcSEcCtD
Mefenamic acid—Anaemia—Rivastigmine—Alzheimer's disease	0.000435	0.00194	CcSEcCtD
Mefenamic acid—Malaise—Memantine—Alzheimer's disease	0.000434	0.00194	CcSEcCtD
Mefenamic acid—Oedema—Donepezil—Alzheimer's disease	0.000432	0.00193	CcSEcCtD
Mefenamic acid—Vertigo—Memantine—Alzheimer's disease	0.000432	0.00193	CcSEcCtD
Mefenamic acid—Syncope—Memantine—Alzheimer's disease	0.000431	0.00193	CcSEcCtD
Mefenamic acid—Leukopenia—Memantine—Alzheimer's disease	0.000431	0.00192	CcSEcCtD
Mefenamic acid—Infection—Donepezil—Alzheimer's disease	0.00043	0.00192	CcSEcCtD
Mefenamic acid—Shock—Donepezil—Alzheimer's disease	0.000425	0.0019	CcSEcCtD
Mefenamic acid—Palpitations—Memantine—Alzheimer's disease	0.000425	0.0019	CcSEcCtD
Mefenamic acid—Malaise—Rivastigmine—Alzheimer's disease	0.000424	0.0019	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000423	0.00189	CcSEcCtD
Mefenamic acid—Vertigo—Rivastigmine—Alzheimer's disease	0.000423	0.00189	CcSEcCtD
Mefenamic acid—Loss of consciousness—Memantine—Alzheimer's disease	0.000423	0.00189	CcSEcCtD
Mefenamic acid—Syncope—Rivastigmine—Alzheimer's disease	0.000422	0.00189	CcSEcCtD
Mefenamic acid—Convulsion—Memantine—Alzheimer's disease	0.000417	0.00186	CcSEcCtD
Mefenamic acid—Palpitations—Rivastigmine—Alzheimer's disease	0.000416	0.00186	CcSEcCtD
Mefenamic acid—Hypertension—Memantine—Alzheimer's disease	0.000415	0.00186	CcSEcCtD
Mefenamic acid—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000414	0.00185	CcSEcCtD
Mefenamic acid—Anorexia—Donepezil—Alzheimer's disease	0.000412	0.00184	CcSEcCtD
Mefenamic acid—Anxiety—Memantine—Alzheimer's disease	0.000408	0.00182	CcSEcCtD
Mefenamic acid—Convulsion—Rivastigmine—Alzheimer's disease	0.000408	0.00182	CcSEcCtD
Mefenamic acid—Hypertension—Rivastigmine—Alzheimer's disease	0.000406	0.00181	CcSEcCtD
Mefenamic acid—Discomfort—Memantine—Alzheimer's disease	0.000405	0.00181	CcSEcCtD
Mefenamic acid—Hypotension—Donepezil—Alzheimer's disease	0.000404	0.0018	CcSEcCtD
Mefenamic acid—Tiaprofenic acid—PTGS1—Alzheimer's disease	0.000403	0.0499	CrCbGaD
Mefenamic acid—Lumiracoxib—PTGS1—Alzheimer's disease	0.000403	0.0499	CrCbGaD
Mefenamic acid—Dry mouth—Memantine—Alzheimer's disease	0.000401	0.00179	CcSEcCtD
Mefenamic acid—Asthenia—Galantamine—Alzheimer's disease	0.0004	0.00179	CcSEcCtD
Mefenamic acid—Anxiety—Rivastigmine—Alzheimer's disease	0.000399	0.00178	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000398	0.00178	CcSEcCtD
Mefenamic acid—Confusional state—Memantine—Alzheimer's disease	0.000396	0.00177	CcSEcCtD
Mefenamic acid—Discomfort—Rivastigmine—Alzheimer's disease	0.000396	0.00177	CcSEcCtD
Mefenamic acid—Oedema—Memantine—Alzheimer's disease	0.000393	0.00175	CcSEcCtD
Mefenamic acid—Dry mouth—Rivastigmine—Alzheimer's disease	0.000392	0.00175	CcSEcCtD
Mefenamic acid—Insomnia—Donepezil—Alzheimer's disease	0.000391	0.00175	CcSEcCtD
Mefenamic acid—Infection—Memantine—Alzheimer's disease	0.00039	0.00174	CcSEcCtD
Mefenamic acid—Paraesthesia—Donepezil—Alzheimer's disease	0.000388	0.00173	CcSEcCtD
Mefenamic acid—Confusional state—Rivastigmine—Alzheimer's disease	0.000387	0.00173	CcSEcCtD
Mefenamic acid—Shock—Memantine—Alzheimer's disease	0.000386	0.00173	CcSEcCtD
Mefenamic acid—Dyspnoea—Donepezil—Alzheimer's disease	0.000386	0.00172	CcSEcCtD
Mefenamic acid—Somnolence—Donepezil—Alzheimer's disease	0.000384	0.00172	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Memantine—Alzheimer's disease	0.000384	0.00172	CcSEcCtD
Mefenamic acid—Oedema—Rivastigmine—Alzheimer's disease	0.000384	0.00172	CcSEcCtD
Mefenamic acid—Nepafenac—PTGS1—Alzheimer's disease	0.000384	0.0474	CrCbGaD
Mefenamic acid—Tachycardia—Memantine—Alzheimer's disease	0.000383	0.00171	CcSEcCtD
Mefenamic acid—Diarrhoea—Galantamine—Alzheimer's disease	0.000382	0.00171	CcSEcCtD
Mefenamic acid—Infection—Rivastigmine—Alzheimer's disease	0.000382	0.0017	CcSEcCtD
Mefenamic acid—Skin disorder—Memantine—Alzheimer's disease	0.000381	0.0017	CcSEcCtD
Mefenamic acid—Dyspepsia—Donepezil—Alzheimer's disease	0.000381	0.0017	CcSEcCtD
Mefenamic acid—Shock—Rivastigmine—Alzheimer's disease	0.000378	0.00169	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000376	0.00168	CcSEcCtD
Mefenamic acid—Decreased appetite—Donepezil—Alzheimer's disease	0.000376	0.00168	CcSEcCtD
Mefenamic acid—Tachycardia—Rivastigmine—Alzheimer's disease	0.000375	0.00167	CcSEcCtD
Mefenamic acid—Anorexia—Memantine—Alzheimer's disease	0.000374	0.00167	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000373	0.00167	CcSEcCtD
Mefenamic acid—Skin disorder—Rivastigmine—Alzheimer's disease	0.000373	0.00167	CcSEcCtD
Mefenamic acid—Constipation—Donepezil—Alzheimer's disease	0.00037	0.00165	CcSEcCtD
Mefenamic acid—Dizziness—Galantamine—Alzheimer's disease	0.000369	0.00165	CcSEcCtD
Mefenamic acid—Hypotension—Memantine—Alzheimer's disease	0.000367	0.00164	CcSEcCtD
Mefenamic acid—Anorexia—Rivastigmine—Alzheimer's disease	0.000366	0.00164	CcSEcCtD
Mefenamic acid—Niflumic Acid—PTGS1—Alzheimer's disease	0.000359	0.0444	CrCbGaD
Mefenamic acid—Hypotension—Rivastigmine—Alzheimer's disease	0.000359	0.0016	CcSEcCtD
Mefenamic acid—Floctafenine—PTGS2—Alzheimer's disease	0.000358	0.0442	CrCbGaD
Mefenamic acid—Feeling abnormal—Donepezil—Alzheimer's disease	0.000356	0.00159	CcSEcCtD
Mefenamic acid—Insomnia—Memantine—Alzheimer's disease	0.000355	0.00159	CcSEcCtD
Mefenamic acid—Vomiting—Galantamine—Alzheimer's disease	0.000355	0.00158	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000354	0.00158	CcSEcCtD
Mefenamic acid—Paraesthesia—Memantine—Alzheimer's disease	0.000353	0.00157	CcSEcCtD
Mefenamic acid—Rash—Galantamine—Alzheimer's disease	0.000352	0.00157	CcSEcCtD
Mefenamic acid—Dermatitis—Galantamine—Alzheimer's disease	0.000351	0.00157	CcSEcCtD
Mefenamic acid—Dyspnoea—Memantine—Alzheimer's disease	0.00035	0.00156	CcSEcCtD
Mefenamic acid—Headache—Galantamine—Alzheimer's disease	0.00035	0.00156	CcSEcCtD
Mefenamic acid—Somnolence—Memantine—Alzheimer's disease	0.000349	0.00156	CcSEcCtD
Mefenamic acid—Insomnia—Rivastigmine—Alzheimer's disease	0.000347	0.00155	CcSEcCtD
Mefenamic acid—Dyspepsia—Memantine—Alzheimer's disease	0.000346	0.00154	CcSEcCtD
Mefenamic acid—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000345	0.00154	CcSEcCtD
Mefenamic acid—Urticaria—Donepezil—Alzheimer's disease	0.000344	0.00153	CcSEcCtD
Mefenamic acid—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000342	0.00153	CcSEcCtD
Mefenamic acid—Body temperature increased—Donepezil—Alzheimer's disease	0.000342	0.00153	CcSEcCtD
Mefenamic acid—Abdominal pain—Donepezil—Alzheimer's disease	0.000342	0.00153	CcSEcCtD
Mefenamic acid—Somnolence—Rivastigmine—Alzheimer's disease	0.000341	0.00153	CcSEcCtD
Mefenamic acid—Decreased appetite—Memantine—Alzheimer's disease	0.000341	0.00152	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000339	0.00151	CcSEcCtD
Mefenamic acid—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000338	0.00151	CcSEcCtD
Mefenamic acid—Constipation—Memantine—Alzheimer's disease	0.000336	0.0015	CcSEcCtD
Mefenamic acid—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000334	0.00149	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000332	0.00148	CcSEcCtD
Mefenamic acid—Nausea—Galantamine—Alzheimer's disease	0.000331	0.00148	CcSEcCtD
Mefenamic acid—Constipation—Rivastigmine—Alzheimer's disease	0.000328	0.00147	CcSEcCtD
Mefenamic acid—Feeling abnormal—Memantine—Alzheimer's disease	0.000324	0.00145	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000321	0.00143	CcSEcCtD
Mefenamic acid—Salsalate—PTGS1—Alzheimer's disease	0.000319	0.0394	CrCbGaD
Mefenamic acid—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000317	0.00141	CcSEcCtD
Mefenamic acid—Meclofenamic acid—PTGS1—Alzheimer's disease	0.000314	0.0388	CrCbGaD
Mefenamic acid—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000314	0.0014	CcSEcCtD
Mefenamic acid—Urticaria—Memantine—Alzheimer's disease	0.000312	0.00139	CcSEcCtD
Mefenamic acid—Abdominal pain—Memantine—Alzheimer's disease	0.00031	0.00139	CcSEcCtD
Mefenamic acid—Body temperature increased—Memantine—Alzheimer's disease	0.00031	0.00139	CcSEcCtD
Mefenamic acid—Asthenia—Donepezil—Alzheimer's disease	0.00031	0.00139	CcSEcCtD
Mefenamic acid—Pruritus—Donepezil—Alzheimer's disease	0.000306	0.00137	CcSEcCtD
Mefenamic acid—Urticaria—Rivastigmine—Alzheimer's disease	0.000305	0.00136	CcSEcCtD
Mefenamic acid—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000304	0.00136	CcSEcCtD
Mefenamic acid—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000304	0.00136	CcSEcCtD
Mefenamic acid—Diarrhoea—Donepezil—Alzheimer's disease	0.000296	0.00132	CcSEcCtD
Mefenamic acid—Dizziness—Donepezil—Alzheimer's disease	0.000286	0.00128	CcSEcCtD
Mefenamic acid—Asthenia—Memantine—Alzheimer's disease	0.000282	0.00126	CcSEcCtD
Mefenamic acid—Pruritus—Memantine—Alzheimer's disease	0.000278	0.00124	CcSEcCtD
Mefenamic acid—Asthenia—Rivastigmine—Alzheimer's disease	0.000276	0.00123	CcSEcCtD
Mefenamic acid—Vomiting—Donepezil—Alzheimer's disease	0.000275	0.00123	CcSEcCtD
Mefenamic acid—Rash—Donepezil—Alzheimer's disease	0.000273	0.00122	CcSEcCtD
Mefenamic acid—Dermatitis—Donepezil—Alzheimer's disease	0.000272	0.00122	CcSEcCtD
Mefenamic acid—Pruritus—Rivastigmine—Alzheimer's disease	0.000272	0.00121	CcSEcCtD
Mefenamic acid—Headache—Donepezil—Alzheimer's disease	0.000271	0.00121	CcSEcCtD
Mefenamic acid—Diarrhoea—Memantine—Alzheimer's disease	0.000269	0.0012	CcSEcCtD
Mefenamic acid—Fenoprofen—PTGS1—Alzheimer's disease	0.000263	0.0326	CrCbGaD
Mefenamic acid—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000263	0.00117	CcSEcCtD
Mefenamic acid—Dizziness—Memantine—Alzheimer's disease	0.00026	0.00116	CcSEcCtD
Mefenamic acid—Nausea—Donepezil—Alzheimer's disease	0.000257	0.00115	CcSEcCtD
Mefenamic acid—Dizziness—Rivastigmine—Alzheimer's disease	0.000254	0.00113	CcSEcCtD
Mefenamic acid—Vomiting—Memantine—Alzheimer's disease	0.00025	0.00112	CcSEcCtD
Mefenamic acid—Rash—Memantine—Alzheimer's disease	0.000248	0.00111	CcSEcCtD
Mefenamic acid—Dermatitis—Memantine—Alzheimer's disease	0.000247	0.0011	CcSEcCtD
Mefenamic acid—Headache—Memantine—Alzheimer's disease	0.000246	0.0011	CcSEcCtD
Mefenamic acid—Vomiting—Rivastigmine—Alzheimer's disease	0.000244	0.00109	CcSEcCtD
Mefenamic acid—Rash—Rivastigmine—Alzheimer's disease	0.000242	0.00108	CcSEcCtD
Mefenamic acid—Dermatitis—Rivastigmine—Alzheimer's disease	0.000242	0.00108	CcSEcCtD
Mefenamic acid—Headache—Rivastigmine—Alzheimer's disease	0.000241	0.00107	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—PTGS1—Alzheimer's disease	0.000238	0.0294	CrCbGaD
Mefenamic acid—Nausea—Memantine—Alzheimer's disease	0.000233	0.00104	CcSEcCtD
Mefenamic acid—Lumiracoxib—PTGS2—Alzheimer's disease	0.000231	0.0285	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS2—Alzheimer's disease	0.000231	0.0285	CrCbGaD
Mefenamic acid—Nausea—Rivastigmine—Alzheimer's disease	0.000228	0.00102	CcSEcCtD
Mefenamic acid—Nepafenac—PTGS2—Alzheimer's disease	0.000219	0.0271	CrCbGaD
Mefenamic acid—Niflumic Acid—PTGS2—Alzheimer's disease	0.000205	0.0254	CrCbGaD
Mefenamic acid—Salicylic acid—PTGS1—Alzheimer's disease	0.000196	0.0242	CrCbGaD
Mefenamic acid—Salsalate—PTGS2—Alzheimer's disease	0.000182	0.0225	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS2—Alzheimer's disease	0.00018	0.0222	CrCbGaD
Mefenamic acid—Diclofenac—PTGS1—Alzheimer's disease	0.000176	0.0217	CrCbGaD
Mefenamic acid—Flurbiprofen—PTGS1—Alzheimer's disease	0.000172	0.0212	CrCbGaD
Mefenamic acid—Ketoprofen—PTGS1—Alzheimer's disease	0.000156	0.0192	CrCbGaD
Mefenamic acid—Fenoprofen—PTGS2—Alzheimer's disease	0.000151	0.0186	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—PTGS2—Alzheimer's disease	0.000136	0.0168	CrCbGaD
Mefenamic acid—Salicylic acid—PTGS2—Alzheimer's disease	0.000112	0.0139	CrCbGaD
Mefenamic acid—Diclofenac—PTGS2—Alzheimer's disease	0.0001	0.0124	CrCbGaD
Mefenamic acid—Flurbiprofen—PTGS2—Alzheimer's disease	9.83e-05	0.0121	CrCbGaD
Mefenamic acid—Ketoprofen—PTGS2—Alzheimer's disease	8.89e-05	0.011	CrCbGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.22e-05	0.000246	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—F2—Alzheimer's disease	3.2e-05	0.000244	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.19e-05	0.000243	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HSD17B10—Alzheimer's disease	3.16e-05	0.000241	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA4—Alzheimer's disease	3.15e-05	0.00024	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.13e-05	0.000239	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—S100B—Alzheimer's disease	3.09e-05	0.000235	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.09e-05	0.000235	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.08e-05	0.000235	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PSENEN—Alzheimer's disease	3.07e-05	0.000234	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	3.04e-05	0.000232	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—NOS3—Alzheimer's disease	3.04e-05	0.000232	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOS2—Alzheimer's disease	3.04e-05	0.000232	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP46A1—Alzheimer's disease	3.04e-05	0.000232	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APH1A—Alzheimer's disease	3.03e-05	0.000231	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOTCH1—Alzheimer's disease	3.01e-05	0.00023	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.97e-05	0.000226	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	2.96e-05	0.000226	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NCSTN—Alzheimer's disease	2.95e-05	0.000225	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IGF2—Alzheimer's disease	2.94e-05	0.000224	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—GSK3B—Alzheimer's disease	2.94e-05	0.000224	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—MTHFR—Alzheimer's disease	2.94e-05	0.000224	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ND1—Alzheimer's disease	2.93e-05	0.000224	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TPI1—Alzheimer's disease	2.93e-05	0.000223	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CHAT—Alzheimer's disease	2.93e-05	0.000223	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CREB1—Alzheimer's disease	2.92e-05	0.000222	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—INS—Alzheimer's disease	2.9e-05	0.000221	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—LRP1—Alzheimer's disease	2.87e-05	0.000219	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.87e-05	0.000219	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCL2—Alzheimer's disease	2.86e-05	0.000218	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IGF1R—Alzheimer's disease	2.84e-05	0.000217	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—GSK3B—Alzheimer's disease	2.83e-05	0.000215	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	2.81e-05	0.000214	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—MAOB—Alzheimer's disease	2.81e-05	0.000214	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IGF1—Alzheimer's disease	2.81e-05	0.000214	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CREB1—Alzheimer's disease	2.8e-05	0.000214	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—INS—Alzheimer's disease	2.79e-05	0.000213	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	2.79e-05	0.000212	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTGS2—Alzheimer's disease	2.78e-05	0.000212	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.78e-05	0.000212	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TPI1—Alzheimer's disease	2.78e-05	0.000212	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CALM1—Alzheimer's disease	2.74e-05	0.000209	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.74e-05	0.000209	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—APOE—Alzheimer's disease	2.73e-05	0.000208	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—LPL—Alzheimer's disease	2.73e-05	0.000208	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CAV1—Alzheimer's disease	2.71e-05	0.000206	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MEF2C—Alzheimer's disease	2.7e-05	0.000206	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GAPDH—Alzheimer's disease	2.7e-05	0.000206	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PLD3—Alzheimer's disease	2.68e-05	0.000204	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.68e-05	0.000204	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.67e-05	0.000204	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PRKCG—Alzheimer's disease	2.65e-05	0.000202	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.65e-05	0.000202	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.65e-05	0.000202	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.62e-05	0.0002	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—A2M—Alzheimer's disease	2.61e-05	0.000199	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EIF2AK2—Alzheimer's disease	2.61e-05	0.000199	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NGF—Alzheimer's disease	2.58e-05	0.000197	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	2.57e-05	0.000196	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—GAPDH—Alzheimer's disease	2.56e-05	0.000195	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NOS3—Alzheimer's disease	2.54e-05	0.000194	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.53e-05	0.000193	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.52e-05	0.000192	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCR5—Alzheimer's disease	2.51e-05	0.000191	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.51e-05	0.000191	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	2.47e-05	0.000189	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HTR2A—Alzheimer's disease	2.46e-05	0.000187	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOS3—Alzheimer's disease	2.45e-05	0.000186	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—TGFB1—Alzheimer's disease	2.4e-05	0.000183	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PSEN2—Alzheimer's disease	2.4e-05	0.000183	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ND1—Alzheimer's disease	2.39e-05	0.000182	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PPARG—Alzheimer's disease	2.38e-05	0.000181	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.35e-05	0.000179	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CST3—Alzheimer's disease	2.34e-05	0.000179	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—INS—Alzheimer's disease	2.34e-05	0.000178	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.33e-05	0.000178	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.33e-05	0.000177	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CHAT—Alzheimer's disease	2.32e-05	0.000177	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TPI1—Alzheimer's disease	2.32e-05	0.000177	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CALM1—Alzheimer's disease	2.29e-05	0.000175	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—LEP—Alzheimer's disease	2.29e-05	0.000174	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APOE—Alzheimer's disease	2.29e-05	0.000174	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ACHE—Alzheimer's disease	2.27e-05	0.000173	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CAV1—Alzheimer's disease	2.26e-05	0.000173	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.26e-05	0.000172	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—INPP5D—Alzheimer's disease	2.24e-05	0.000171	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—Alzheimer's disease	2.24e-05	0.00017	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—MAOB—Alzheimer's disease	2.23e-05	0.00017	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IAPP—Alzheimer's disease	2.19e-05	0.000167	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ESR1—Alzheimer's disease	2.18e-05	0.000166	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CASP3—Alzheimer's disease	2.16e-05	0.000165	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—F2—Alzheimer's disease	2.16e-05	0.000164	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GAPDH—Alzheimer's disease	2.15e-05	0.000163	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.14e-05	0.000163	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ENO1—Alzheimer's disease	2.13e-05	0.000162	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.12e-05	0.000162	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOTCH1—Alzheimer's disease	2.11e-05	0.000161	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.1e-05	0.00016	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP2D6—Alzheimer's disease	2.09e-05	0.000159	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—A2M—Alzheimer's disease	2.07e-05	0.000158	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.07e-05	0.000158	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.06e-05	0.000157	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—NOS3—Alzheimer's disease	2.05e-05	0.000156	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ENO1—Alzheimer's disease	2.02e-05	0.000154	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PPP3CA—Alzheimer's disease	2.01e-05	0.000153	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK8—Alzheimer's disease	1.99e-05	0.000151	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—GSK3B—Alzheimer's disease	1.98e-05	0.000151	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—BCHE—Alzheimer's disease	1.98e-05	0.000151	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CREB1—Alzheimer's disease	1.96e-05	0.00015	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—INS—Alzheimer's disease	1.95e-05	0.000149	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—GAB2—Alzheimer's disease	1.92e-05	0.000147	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCL2—Alzheimer's disease	1.92e-05	0.000146	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—GSK3A—Alzheimer's disease	1.91e-05	0.000145	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—AKT1—Alzheimer's disease	1.91e-05	0.000145	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CHAT—Alzheimer's disease	1.89e-05	0.000144	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TPI1—Alzheimer's disease	1.89e-05	0.000144	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IGF1—Alzheimer's disease	1.89e-05	0.000144	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APP—Alzheimer's disease	1.87e-05	0.000143	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—Alzheimer's disease	1.87e-05	0.000143	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PLCB1—Alzheimer's disease	1.87e-05	0.000142	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.85e-05	0.000141	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.84e-05	0.00014	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—Alzheimer's disease	1.83e-05	0.00014	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.83e-05	0.00014	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.81e-05	0.000138	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IL6—Alzheimer's disease	1.81e-05	0.000138	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ABCA1—Alzheimer's disease	1.81e-05	0.000138	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ACHE—Alzheimer's disease	1.8e-05	0.000137	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—INPP5D—Alzheimer's disease	1.78e-05	0.000136	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.75e-05	0.000133	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.75e-05	0.000133	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.73e-05	0.000132	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOS3—Alzheimer's disease	1.71e-05	0.000131	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.71e-05	0.00013	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PTGS1—Alzheimer's disease	1.69e-05	0.000129	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ENO1—Alzheimer's disease	1.69e-05	0.000129	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.69e-05	0.000128	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TGFB1—Alzheimer's disease	1.68e-05	0.000128	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.68e-05	0.000128	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—AKT1—Alzheimer's disease	1.67e-05	0.000127	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	1.66e-05	0.000126	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TGFB1—Alzheimer's disease	1.62e-05	0.000123	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ADAM10—Alzheimer's disease	1.61e-05	0.000123	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—BCHE—Alzheimer's disease	1.57e-05	0.00012	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	1.56e-05	0.000119	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—HMOX1—Alzheimer's disease	1.55e-05	0.000118	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.54e-05	0.000117	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.54e-05	0.000117	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.5e-05	0.000115	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PLCB1—Alzheimer's disease	1.48e-05	0.000113	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.48e-05	0.000112	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.47e-05	0.000112	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CASP3—Alzheimer's disease	1.45e-05	0.000111	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.45e-05	0.00011	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ABCA1—Alzheimer's disease	1.44e-05	0.000109	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.42e-05	0.000108	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—LPL—Alzheimer's disease	1.42e-05	0.000108	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.4e-05	0.000107	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—AKT1—Alzheimer's disease	1.4e-05	0.000107	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.39e-05	0.000106	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—Alzheimer's disease	1.39e-05	0.000106	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.37e-05	0.000105	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.37e-05	0.000105	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.37e-05	0.000105	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.35e-05	0.000103	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—LPL—Alzheimer's disease	1.35e-05	0.000103	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK8—Alzheimer's disease	1.34e-05	0.000102	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PRKCG—Alzheimer's disease	1.31e-05	9.97e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—MTHFR—Alzheimer's disease	1.28e-05	9.74e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—BCHE—Alzheimer's disease	1.28e-05	9.74e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6—Alzheimer's disease	1.27e-05	9.66e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CCR5—Alzheimer's disease	1.24e-05	9.45e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	1.24e-05	9.43e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—Alzheimer's disease	1.23e-05	9.4e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—HMOX1—Alzheimer's disease	1.23e-05	9.39e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.22e-05	9.32e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6—Alzheimer's disease	1.22e-05	9.29e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MTHFR—Alzheimer's disease	1.21e-05	9.23e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	1.21e-05	9.19e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CALM1—Alzheimer's disease	1.19e-05	9.1e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.19e-05	9.1e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOE—Alzheimer's disease	1.19e-05	9.07e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.18e-05	9.01e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.18e-05	8.99e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CAV1—Alzheimer's disease	1.18e-05	8.98e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-05	8.92e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	1.17e-05	8.91e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TGFB1—Alzheimer's disease	1.13e-05	8.63e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CALM1—Alzheimer's disease	1.13e-05	8.63e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOE—Alzheimer's disease	1.13e-05	8.6e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—LPL—Alzheimer's disease	1.13e-05	8.59e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—AKT1—Alzheimer's disease	1.12e-05	8.57e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.12e-05	8.52e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.12e-05	8.52e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CAV1—Alzheimer's disease	1.12e-05	8.52e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.1e-05	8.36e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS2—Alzheimer's disease	1.05e-05	8.01e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOTCH1—Alzheimer's disease	1.04e-05	7.93e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—BCHE—Alzheimer's disease	1.04e-05	7.92e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARG—Alzheimer's disease	1.04e-05	7.9e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—INS—Alzheimer's disease	1.02e-05	7.75e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—MTHFR—Alzheimer's disease	1.01e-05	7.73e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	1.01e-05	7.68e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	1e-05	7.64e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	9.81e-06	7.48e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—GSK3B—Alzheimer's disease	9.77e-06	7.44e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CREB1—Alzheimer's disease	9.69e-06	7.38e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—INS—Alzheimer's disease	9.63e-06	7.34e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.62e-06	7.33e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	9.51e-06	7.25e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CALM1—Alzheimer's disease	9.48e-06	7.22e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOE—Alzheimer's disease	9.45e-06	7.2e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—AKT1—Alzheimer's disease	9.41e-06	7.17e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CAV1—Alzheimer's disease	9.36e-06	7.13e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—Alzheimer's disease	9.32e-06	7.1e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LPL—Alzheimer's disease	9.17e-06	6.99e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NOS3—Alzheimer's disease	8.91e-06	6.79e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6—Alzheimer's disease	8.53e-06	6.5e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS3—Alzheimer's disease	8.45e-06	6.44e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	8.26e-06	6.29e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARG—Alzheimer's disease	8.23e-06	6.27e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	8.2e-06	6.25e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	8.16e-06	6.22e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—Alzheimer's disease	8.15e-06	6.21e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—INS—Alzheimer's disease	8.07e-06	6.15e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AKT1—Alzheimer's disease	7.87e-06	6e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CALM1—Alzheimer's disease	7.71e-06	5.88e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOE—Alzheimer's disease	7.69e-06	5.86e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CAV1—Alzheimer's disease	7.61e-06	5.8e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LPL—Alzheimer's disease	7.46e-06	5.69e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NOS3—Alzheimer's disease	7.08e-06	5.39e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	6.72e-06	5.12e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARG—Alzheimer's disease	6.69e-06	5.1e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—INS—Alzheimer's disease	6.57e-06	5e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CALM1—Alzheimer's disease	6.28e-06	4.78e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOE—Alzheimer's disease	6.25e-06	4.77e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CAV1—Alzheimer's disease	6.2e-06	4.72e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NOS3—Alzheimer's disease	5.76e-06	4.39e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFB1—Alzheimer's disease	5.59e-06	4.26e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARG—Alzheimer's disease	5.45e-06	4.15e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—INS—Alzheimer's disease	5.34e-06	4.07e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	5.27e-06	4.01e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NOS3—Alzheimer's disease	4.69e-06	3.57e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	4.29e-06	3.27e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6—Alzheimer's disease	4.21e-06	3.21e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AKT1—Alzheimer's disease	4.1e-06	3.12e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKT1—Alzheimer's disease	3.88e-06	2.96e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKT1—Alzheimer's disease	3.25e-06	2.48e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKT1—Alzheimer's disease	2.65e-06	2.02e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKT1—Alzheimer's disease	2.15e-06	1.64e-05	CbGpPWpGaD
